(Q24244908)

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Improving placental blood flow in pre‐eclampsia with prostaglandin A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

A new treatment of severe pre-eclampsia by long-term epidural anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Long-term treatment with nicardipine for severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

The optimal dosage of ketanserin for patients with severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Digoxin immune fab treatment for severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Hyperuricaemia and preeclampsia: is there a pathogenic link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Interventionist versus expectant care for severe pre-eclampsia before term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Plasma volume expansion for treatment of women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Magnesium sulphate versus lytic cocktail for eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Pre-eclampsia: more than pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

Oral nifedipine therapy in the management of severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Management of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Efficacy of AT in pre-eclampsia: a case-control prospective trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

Phosphodiesterase Inhibitor Effect on Small Artery Function in Preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001449.PUB2

7 January 2021

10.1002/14651858.CD001449.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16855969

1 reference

Consolidated OpenCitations Corpus – April 2017